---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-072253"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:17:24.698876+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health enters $50M incremental term loan amendment to credit agreement

## Summary
- Incurred $50M incremental term loans on June 16, 2023 under amended credit agreement.
- Proceeds used to repay revolving credit loans; quarterly payments of $1.25M begin Sep 30, 2023.
- Loans mature April 22, 2026; interest rates range from SOFR 2.00% to 2.75% based on leverage.
- Amendment adds a pricing grid tier and was executed by required lenders and the administrative agent.
- Existing guarantees and collateral continue to secure all obligations under the credit facility.

## SEC filing metadata
- accession: 0001104659-23-072253
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000110465923072253/0001104659-23-072253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000110465923072253/tm2318884d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-072253
- JSON: https://secwatch.observer/filing/0001104659-23-072253.json
- Plain text: https://secwatch.observer/filing/0001104659-23-072253.txt

## Key facts
- Debt Financings
  PHIBRO ANIMAL HEALTH CORP incurred term loan of $50,000,000 with Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders at Base Rate for 2023 Incremental Term Loans ranging from 1.00% to 1.75%; Term SOFR maturing April 22, 2026.
  - Instrument: term loan
  - Principal: $50,000,000
  - Counterparty: Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders
  - Rate: Base Rate for 2023 Incremental Term Loans ranging from 1.00% to 1.75%; Term SOFR
  - Maturity: April 22, 2026
  - Event: incurrence
  source text: The Second Amendment amends the Existing Credit Agreement to, among other things, (i) incur incremental term loans in an aggregate principal amount of $50,000,000 (the “2023 Incremental Term Loans”) and (ii) add an additional level to the existing Term Loan and Revolving Credit Facility pricing grid.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465923072253/0001104659-23-072253-index.htm
- Material Agreements
  PHIBRO ANIMAL HEALTH CORP amended Amended and Restated Credit Agreement, as amended by Amendment No. 2 with Bank of America, N.A. valued at incremental term loans in an aggregate principal amount of $50,000,000 (effective 2023-06-16).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Bank of America, N.A.
  - Value: incremental term loans in an aggregate principal amount of $50,000,000
  - Effective: 2023-06-16
  source text: Item 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On June 16, 2023 (the "Amendment No. 2 Effective Date"), Phibro Animal Health Corporation (the "Company") entered into Amendment No. 2 (the "Second Amendment") to that certain Amended and Restated Credit Agreement, dated as of April 22, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified as of the date hereof, the "Existing Credit Agreement," and, as further amended by the Second Amendment, the "Credit Agreement"), among the Company, certain of its subsidiaries acting as guarantors, Bank of America, N.A., as administrative agent, the 2023 Incremental Term Loan Lenders and the Consenting Lenders (each as defined in the Second Amendment).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465923072253/0001104659-23-072253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.